• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

JAMA Internal Medicine

JAMA editorial slams FDA over adverse-event reporting

January 9, 2020 By Nancy Crotti

This article has been updated with comments from the FDA. A recent JAMA Internal Medicine editorial takes another swipe at the FDA for delays in improving its medical device adverse-event reporting. Journal editor Dr. Rita Redberg and Dr. James Salazar, both of Department of Medicine, University of California, San Francisco, note several instances in which […]

Filed Under: Cardiovascular, Featured, Food & Drug Administration (FDA), Recalls, Regulatory/Compliance Tagged With: FDA, JAMA Internal Medicine, Medtronic, stjudemedical, Unique Device Identifier (UDI)

Study: Abbott, Edwards may have mislabeled hundreds of patient deaths

October 8, 2019 By Nancy Crotti

This report has been updated with comments from Edwards Lifesciences, Madris Tomes and the FDA. Abbott (NYSE:ABT) and Edwards Lifesciences (NYSE:EW) may have mislabeled patient deaths as injuries or device malfunctions in hundreds of FDA adverse event reports involving their transcatheter aortic or mitral valve replacement devices, according to a new study. The study by JAMA […]

Filed Under: Cardiac Implants, Featured, Food & Drug Administration (FDA), Implants, Replacement Heart Valves Tagged With: Abbott, deviceevents, Edwards Lifesciences, FDA, JAMA Internal Medicine

Netflix’s ‘The Bleeding Edge’ blasts medtech & FDA

July 27, 2018 By Nancy Crotti

Netflix has unleashed a blistering indictment of the medical device industry, the FDA and doctors who accept money from medtech in its new documentary, ‘The Bleeding Edge,’ released today. The film depicts people who have suffered injuries and/or illnesses following placement of Bayer’s Essure sterilization device, Johnson & Johnson’s vaginal mesh, various manufacturers’ metal artificial […]

Filed Under: 510(k), Food & Drug Administration (FDA), Gynecological, Metal-on-Metal, Neurological, Pre-Market Approval (PMA), Regulatory/Compliance Tagged With: AdvaMed, Bayer, British Medical Journal, FDA, Intuitive Surgical, JAMA Internal Medicine, Johnson and Johnson

Study: Medical device trials still ignoring gender, age, race

July 24, 2017 By Fink Densford

Despite FDA guidelines, very few medical device trials are analyzed to consider how a user’s sex, age or race could affect safety and effectiveness of the device, according to a new study out of Yale and the University of California-San Francisco. Results from the study were published in Jama Internal Medicine. The study aimed to […]

Filed Under: Clinical Trials Tagged With: JAMA Internal Medicine

Study: U.S. patients subject to higher radiation during MPI heart test

December 29, 2015 By Fink Densford

Americans undergoing myocardial perfusion imaging to diagnose coronary artery disease, a leading killer in the U.S., are receiving higher levels of radiation than their peers around the world, according to a new study. The study was published in JAMA Internal Medicine this month. The MPI test, performed on millions of U.S. patients every year, is […]

Filed Under: Cardiovascular, Clinical Trials Tagged With: JAMA Internal Medicine

Study: Uncommon form of heart attack likely runs in family

March 23, 2015 By MassDevice Leave a Comment

Study: Uncommon form of heart attack likely runs in family

(Reuters) — Although oncologists increasingly distinguish breast, lung, and other cancers by their molecular drivers, cardiologists have lagged behind in efforts to do something similar for heart disease.

Filed Under: Cardiovascular, News Well Tagged With: Clinical Trials, JAMA Internal Medicine

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS